CNN SSRS Poll: President Trump's approval rating has fallen to a career low of thirty-four percent. Americans are increasingly dissatisfied...

The higher you rise, the tricker it gets to talk about your wins. You’re often not the one building the financial model, writing the code, ...

Artificial intelligence is often hailed as a game changer, but too many firms discover that their bold AI pilots collapse when their operat...

CDSCO still faces challenges like chronic understaffing, gaps in technical skills, weak lab infra and fragmented approvals. About a decade ...

India's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...

The U.S. Food and Drug Administration's drug center sees a leadership change as acting head Tracy Beth Hoeg departs, replaced by deputy Mic...

The US Food and Drug Administration will expedite reviews for nicotine pouches from four tobacco firms. This pilot program starts on Monday...

Vinay Prasad, the Food and Drug Administration's chief medical and science officer, resigned. He cited a desire to return to California and...

Vinay Prasad, an oncologist-hematologist, has been appointed as the new director of the FDA's CBER, overseeing vaccines and genetic medicin...

Patel has a 13-year tenure at the US FDA and has contributed to transforming the healthcare industry and mainstreaming digital health.

Dr. Reddy’s informed stock exchanges that 3 of its key sites received warning letters from US FDA and will need to submit correction plans ...

The sites of leading drugmakers such as Ranbaxy Laboratories, Wockhardt, Strides Arcolab and Sun Pharma are on the USFDA list.

"Companies must ensure that they are saying what they do and they do what they say and demonstrate that they did it" said Leslie Ball of FD...

To do public policy in India, the skill required is that of an engineer and not the driver. It is about opening the hood, understanding wha...

US FDA raising issues questioning the company’s integrity and transparency are likely to have long term ramifications on its oversees busin...

Daiichi Sankyo, the Japanese pharmaceutical company that bought Ranbaxy Laboratories last year, will meet US FDA officials next month to so...

Law makers are seizing on last month’s study linking GlaxoSmithKline’s diabetes drug Avandia and heart risks to press for new US drug-safet...